| Financial Year |
March 31 2023 |
| Monetary Funds |
50,941,790.43 |
| Held-for-trading Financial Assets |
40,904,985.82 |
| Notes Receivable |
12,222,263.21 |
| Accounts Receivable |
220,505,104.10 |
| Advances to Suppliers |
16,336,404.44 |
| Other Receivables |
7,650,504.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,821,141.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,967,764.51 |
| Total Current Assets |
433,862,458.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
199,845,465.01 |
| Investment Properties |
6,205,739.58 |
| Fixed Assetes |
80,976,455.96 |
| Under-construction Projects |
579,811.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,804,425.37 |
| R&D expenses |
-- |
| Goodwill |
39,968,439.62 |
| Long-Term Deferred and Prepaid Expenses |
100,625.00 |
| Deferred Income Tax Assets |
3,553,491.82 |
| Other Non-Current Assets |
46,966.98 |
| Sub-Total of Non-Current Assets |
413,718,007.25 |
| Total Assets |
847,580,465.88 |
| Short-Term Loans |
90,107,589.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
50,322,135.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,962,311.08 |
| Taxes Payable |
14,066,751.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,035,288.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
442,498.20 |
| Other Current Liabilities |
4,754,345.74 |
| Sub-Total of Current Liabilities |
176,962,791.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,938.56 |
| Total Liabilities |
177,009,730.35 |
| Paid-In Capital(Or Share Stock) |
99,490,300.00 |
| Capital Surplus |
299,291,534.13 |
| Surplus Reserve |
31,250,554.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
219,019,474.64 |
| Minority Stockholder's Interest |
21,518,872.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
649,051,863.51 |
| Owner's Equity（Stockholder's Equity） |
670,570,735.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
847,580,465.88 |
